Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme

by Alice Bessey, James B Chilcott, Joanna Leaviss, Anthea Sutton
Published 2018-10-01

A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK

by Alice Bessey, James Chilcott, Joanna Leaviss, Carmen de la Cruz, Ruth Wong
Published 2019-08-01

What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation

by Joanna Leaviss, William Sullivan, Shijie Ren, Emma Everson-Hock, Matt Stevenson, John W Stevens, Mark Strong, Anna Cantrell
Published 2014-05-01

Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation

by Joanna Leaviss, Sarah Davis, Shijie Ren, Jean Hamilton, Alison Scope, Andrew Booth, Anthea Sutton, Glenys Parry, Marta Buszewicz, Rona Moss-Morris, Peter White
Published 2020-09-01

What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation

by Katy Cooper, Alan Brennan, Helen Buckley Woods, Chloe Thomas, Penny Breeze, Michael Gillett, Edward Goka, Hazel Y Squires, Gilly Brenner, Joanna Leaviss, Mark Clowes, Laura Heathcote
Published 2020-09-01